Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.43730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Laura Von Kobyletzki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Department of…. Hauptthemen laut MEDLINE: Prurigo, Health Care Costs, Practice Patterns, Physicians', Patient Acceptance of Health Care. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prurigo nodularis (PN) is a chronic, itchy, inflammatory skin condition that negatively affects quality of life. A study was undertaken to investigate the healthcare utilization, including treatment patterns and direct costs for specialist care, for PN in Sweden. Linkage cohorts were created from national Swedish patient and prescription registers, and the cost-per-patient database of PN adults in specialist care in Sweden from 2015 to 2020. Around 875 patients were registered annually with a specialist diagnosis of PN in Sweden, with 3,548 specialist visits per year on average. In patients with severe PN with AD, the most common treatment sequence was topical treatment with corticosteroids followed by systemic prednisolone and methotrexate (32.6%). More than one-fifth of individuals with PN, and most with severe PN, had treatment for more than 1 year. For in- and outpatient care, the mean cost per visit was €458.6 and per patient per year around €1,862. The total annual cost of PN patients is estimated to be €1.6 million in Sweden. A high proportion of patients are treated for years with several, often systemic, treatment sequels. Targeted treatments for PN might improve patients’ quality of life and reduce the high related costs for the healthcare system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Department of Occupational and Environmental Dermatology, Skåne University Hospital…
- Örebro University, School of Medical Sciences, Örebro, Sweden; Department of Healthcare, Knowledge Support Unit, Region Värmland, Sweden.
- Sanofi AB, Stockholm, Sweden.
- Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Department of Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
- Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden. annarita.antelmi@med.lu.se.
Zitieren
APA
Von Kobyletzki, L., Metsini, A., Regnell, S. E., Carlberg, M., Svensson, Å., & Antelmi, A. (2025). Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.43730
Vancouver
Von Kobyletzki L, Metsini A, Regnell SE, Carlberg M, Svensson Å, Antelmi A. Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.43730
BibTeX
@article{VonKobyletzki2025,
author = {Von Kobyletzki, Laura and Metsini, Alexandra and Regnell, Simon E and Carlberg, Michael and Svensson, Åke and Antelmi, Annarita},
title = {Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.43730}
}
EUVIMED